SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-21-007073
Filing Date
2021-02-05
Accepted
2021-02-05 16:23:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE 13G ea134724-13ga4eddle_repligen.htm SC 13G/A 60418
  Complete submission text file 0001213900-21-007073.txt   61718
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Subject) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-38071 | Film No.: 21595765
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 110 W. GEORGE BURNS ROAD SUITE D-4018 LOS ANGELES CA 90048
Business Address
EDDLEMAN ROY T (Filed by) CIK: 0001270264 (see all company filings)

Type: SC 13G/A